Response to the Letter to the Editor concerning ‘Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis’
Saved in:
| Main Authors: | Ivana Stević, Slobodan M. Janković |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Biotechnology & Biotechnological Equipment |
| Online Access: | https://www.tandfonline.com/doi/10.1080/13102818.2024.2386488 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Letter to the Editor concerning ‘cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis’
by: A. L. Stevenson, et al.
Published: (2024-12-01) -
P244: Clinical profiles of 134 patients with alpha-mannosidosis from the velmanase alfa clinical program and SPARKLE registry
by: Heather Morgan, et al.
Published: (2025-01-01) -
Alfa-mannosidosis: Frequent Symptoms in Rare Patient
by: Nato D. Vashakmadze, et al.
Published: (2023-01-01) -
Alpha-mannosidosis and mutational analysis in a Turkish patient
by: Akgün Olmez, et al.
Published: (2003-01-01) -
Disease profile in a cohort of Brazilian patients diagnosed with alpha-mannosidosis
by: Fabiano de Oliveira Poswar, et al.
Published: (2025-06-01)